Innsbruck, Austria

Ernst Ellmerer-Müller

This inventor holds 1 USPTO granted patent. Top assignee: C-Chem Ag. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ernst Ellmerer-Müller. Retrieved from https://idiyas.com/inventor/ernst-ellmerer-manduumlller

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ernst Ellmerer-Müller

Introduction

Ernst Ellmerer-Müller is a notable inventor based in Innsbruck, Austria. He has made significant contributions to the field of pharmaceuticals, particularly with his work on cyclosporins. His innovative approach has led to the development of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Ernst Ellmerer-Müller holds a patent for cyclosporins, which are crucial in the field of immunosuppressive therapy. This patent highlights his commitment to improving patient outcomes through innovative pharmaceutical solutions. He has 1 patent to his name, reflecting his focused contributions to the industry.

Career Highlights

Throughout his career, Ernst has worked with C-Chem AG, a company that specializes in chemical innovations. His role at C-Chem AG has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to pharmaceutical research and development.

Collaborations

Some of his notable coworkers include Najib Maslouh and Dagmar Brössner. Their collaborative efforts have played a significant role in advancing the projects they have worked on together, fostering an environment of innovation and creativity.

Conclusion

Ernst Ellmerer-Müller is a distinguished inventor whose work on cyclosporins has made a lasting impact in the pharmaceutical industry. His dedication to innovation and collaboration continues to inspire advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…